On 18 February, MetLife, Inc. (NYSE:MET) shares decreased -0.18% and were closed at $39.20. MET EPS growth in last 5 year was 10.30%. MetLife, Inc. (NYSE:MET) year to date (YTD) performance is -17.97%.
MetLife, Inc. (NYSE:MET) announced that it will hold an investor conference on Thursday, Sept. 29, 2016, in New York City. Presenters will include members of MetLife’s senior management team.
Merck & Co. Inc. (NYSE:MRK) shares decreased -0.55% in last trading session and ended the day at $50.32. MRK Gross Margin is 62.20% and its has a return on assets of 7.70%. Merck & Co. Inc. (NYSE:MRK) quarterly performance is -5.48%.
On 5 February, Merck & Co. Inc. (NYSE:MRK) issued cautious 2016 revenue and earnings forecasts after disappointing fourth-quarter demand for its Januvia diabetes treatment and its Remicade arthritis drug. Sales of Januvia and a related drug called Janumet, the company’s biggest franchise, fell 12 percent to $1.45 billion. Merck said their tumble was due in large part to timing of customer purchases in the third quarter. Competition from a growing number of other oral diabetes treatments also hurt sales.
3M Company (NYSE:MMM) caters to the Industrial Goods space. It has a net profit margin of 16.00% and weekly performance is 2.84%. On the last day of trading company shares ended up at $156.78. 3M Company (NYSE:MMM) distance from 50-day simple moving average (SMA50) is 6.17%.
3M Company (NYSE:MMM) has announced that it will raise its quarterly dividend by 8% from $1.025 to $1.11 for the first quarter of 2016. Additionally, the firm has declared that it will pursue a $10 billion share buyback scheme, replacing the $12 billion plan announced in 2014, which still had $1.5 billion remaining at the end of 2015. No details were given as to when the company intends to end the scheme.
Alliqua Biomedical Inc (NASDAQ:ALQA) shares moved down -12.33% in last trading session and ended the day at $1.28. ALQA Gross Margin is 50.40% and its has a return on assets of -43.60%. Alliqua Biomedical Inc (NASDAQ:ALQA) quarterly performance is -52.42%.
Alliqua Biomedical Inc (NASDAQ:ALQA) said that, it offers wound care solutions. The company conducts businesses that include wound care, transdermal drug delivery, and contract manufacturing. Its wound care business manufactures and markets wound dressings that include BIOVANCE, SilverSeal, Hydress, sorbion sachet S, and sorbion sana gentle.
SunEdison, Inc. (NYSE:SUNE) caters to the Technology space. It has a net profit margin of -62.50% and weekly performance is -36.02%. On the last day of trading company shares ended up at $1.51. SunEdison, Inc. (NYSE:SUNE) distance from 50-day simple moving average (SMA50) is -59.67%.
On 9 February, SunEdison, Inc. (NYSE:SUNE) announced it has signed a solar power purchase agreement with Stockton East Water District in Northern California. SunEdison plans to install 2.2 megawatts of high-performance SunEdison solar panels on the water district’s property. By going solar, the district expects to save more than $9.5 million on energy costs over the next 20 years and 20 million gallons of water annually.